These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 10469456)

  • 21. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
    Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
    Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder.
    Kimura F; Florl AR; Seifert HH; Louhelainen J; Maas S; Knowles MA; Schulz WA
    Br J Cancer; 2001 Dec; 85(12):1887-93. PubMed ID: 11747331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder.
    Keen AJ; Knowles MA
    Oncogene; 1994 Jul; 9(7):2083-8. PubMed ID: 8208555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines.
    Williams SV; Sibley KD; Davies AM; Nishiyama H; Hornigold N; Coulter J; Kennedy WJ; Skilleter A; Habuchi T; Knowles MA
    Genes Chromosomes Cancer; 2002 May; 34(1):86-96. PubMed ID: 11921286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definition of a 1-Mb homozygous deletion at 9q32-q33 in a human bladder-cancer cell line.
    Fujiwara H; Emi M; Nagai H; Ohgaki K; Imoto I; Akimoto M; Ogawa O; Habuchi T
    J Hum Genet; 2001; 46(7):372-7. PubMed ID: 11450846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33.
    Habuchi T; Luscombe M; Elder PA; Knowles MA
    Genomics; 1998 Mar; 48(3):277-88. PubMed ID: 9545632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel bladder tumour suppressor genes.
    Knowles MA
    Electrophoresis; 1999 Feb; 20(2):269-79. PubMed ID: 10197433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction.
    Cairns P; Tokino K; Eby Y; Sidransky D
    Cancer Res; 1994 Mar; 54(6):1422-4. PubMed ID: 8137242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High frequency loss of heterozygosity in the region of the DBH locus in bladder cancer.
    Yang X; Shen P; Yao K; Mi Z; Liu S; Zhang H; Wang D; Liu C; Liu H
    Chin Med J (Engl); 2000 Feb; 113(2):117-9. PubMed ID: 11775532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
    Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
    Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of chromosome 9 in human bladder cancer.
    Miyao N; Tsai YC; Lerner SP; Olumi AF; Spruck CH; Gonzalez-Zulueta M; Nichols PW; Skinner DG; Jones PA
    Cancer Res; 1993 Sep; 53(17):4066-70. PubMed ID: 8358736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.
    Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B
    Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder.
    Cappellen D; Gil Diez de Medina S; Chopin D; Thiery JP; Radvanyi F
    Oncogene; 1997 Jun; 14(25):3059-66. PubMed ID: 9223669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb.
    Bell SM; Zuo J; Myers RM; Knowles MA
    Genes Chromosomes Cancer; 1996 Oct; 17(2):108-17. PubMed ID: 8913728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
    Cairns P; Shaw ME; Knowles MA
    Oncogene; 1993 Apr; 8(4):1083-5. PubMed ID: 8096074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes.
    Kagan J; Stein J; Babaian RJ; Joe YS; Pisters LL; Glassman AB; von Eschenbach AC; Troncoso P
    Oncogene; 1995 Nov; 11(10):2121-6. PubMed ID: 7478532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer.
    Merlo A; Gabrielson E; Mabry M; Vollmer R; Baylin SB; Sidransky D
    Cancer Res; 1994 May; 54(9):2322-6. PubMed ID: 8162574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.
    Stadler WM; Sherman J; Bohlander SK; Roulston D; Dreyling M; Rukstalis D; Olopade OI
    Cancer Res; 1994 Apr; 54(8):2060-3. PubMed ID: 7513608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer.
    Pulido HA; Fakruddin MJ; Chatterjee A; Esplin ED; Beleño N; Martinez G; Posso H; Evans GA; Murty VV
    Cancer Res; 2000 Dec; 60(23):6677-82. PubMed ID: 11118052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.